BACKGROUND
Hepatitis is a global health problem. WHO estimates, there are 257 million people infected with hepatitis B and suffer from chronic hepatitis B, 71 million people are infected with hepatitis C and suffer from chronic hepatitis C. Every year, 1.34 million deaths due to viral hepatitis (acute, cirrhosis and liver cancer); where there were 720,000 deaths (half mixed) due to cirrhosis and 470,000 deaths due to liver cancer (Source: Global Hepatitis Report, WHO 2017).
In Indonesia, hepatitis B and C virus infections are also the most common cause of complications of chronic hepatitis, namely cirrhosis and liver cancer, which ends in death. Cirrhosis of the liver is one of the 10 leading causes of death in Indonesia (the top 10 in the burden of disease in 2017). Deaths due to cirrhosis decreased from rank four in 2007 to rank fifth in 2017, in line with an increase in strokes, ischemic heart disease, and diabetes. However, the proportion of cirrhosis events has increased by 5.6% over the past 10 years.
Sub Directorate Hepatitis and GITID (Gastrointestinal Tract Infectious Diseases) Ministry of Health in term of strengthening the Hepatitis B and C program has launched several interventions such as improved access for early Hepatitis B detection among pregnant women including giving Hepatitis B Immunoglobulin (HBIG) to infant who is born to a Hepatitis B positive mother and timely immunization with the Hepatitis B vaccine birth dose. Sub Directorate Hepatitis and GITID also provide Direct Acting Antiviral (DAA) treatment for hepatitis C patients; the treatment is known for producing a 95% cure rate. The sub-directorate is also working to ensure the hepatitis financing into national health insurance scheme. This planning also involves strengthening surveillance and data management and monitoring systems.
WHO will support the Hepatitis and GITID Sub Directorate with data management and programmatic management assistance.
OBJECTIVES OF THE PROGRAMME:
To provide technical support to Hepatitis sub-directorate for the expansion of sustainable, decentralized, and integrated service delivery models that address a hepatitis prevention, treatment, and care cascade of services for both HCV and HBV. This will, include triple elimination under prevention of mother-to-child transmission (PMTCT) within the framework of Universal Health Coverage.
SUMMARY OF ASSIGNED DUTIES:
The incumbent will work under the direct and managerial supervision of the WHO HIV/STI/HEP Team Leader/Technical Officer, and in compliance with project guidelines in the assigned district/province listed as below.
In the context of WCO Indonesia’s Intensified Support and Action in Countries (ISAC) for Hepatitis Control Program as Public Health intervention, the set of roles and responsibilities will cover technical support to Hepatitis program following the National Health Priority.
Specifically, the incumbent will:
REQUIRED QUALIFICATIONS
Education:
Essential: Master’s degree in Medicine or Public Health, epidemiology, or related health sciences.
Desirable: Post-graduate degree in Community Medicine, Public Health, or related fields.
Experience:
Essential:
Desirable: Having experience of working within MoH units like infectious disease sub-directorate, puskesmas, district health office. Experience of working in Hepatitis control is an added advantage
Skills:
Competencies:
.
Languages:
Excellent knowledge of written and spoken English and working knowledge of local language will be an asset.
Other Skills (e.g. IT):
Work is performed in normal working environment.
Computer literacy: Proficient in the use of Microsoft Office applications.
Remuneration:
SSA National Consultant – Hepatitis, Level A. Between IDR 25,708,600 and 41,419,267 (in accordance with WHO Salary Scale for SSA).
ADDITIONAL INFORMATION